US Bancorp’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

US Bancorp’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,000	Closed	-$30K	–	3739
2016 Q2	$30K	Buy	+1,000	New	+$20.3K	﹤0.01%	2649

US Bancorp's CPXX Position: Q3 2016 in Review

US Bancorp sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 1,000 shares — an estimated $30K sold.

US Bancorp first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $30K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

US Bancorp reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
US Bancorp sold 1,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $30K.
US Bancorp first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
US Bancorp's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $30K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.